Grace Therapeutics GRCE
NASDAQ GRCE
$1.97 -0.01 (-0.51%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) Long-Term Investments (2018 - 2019)

Updated

Grace Therapeutics (GRCE) recorded Long-Term Investments of $20,302 in fiscal Q4 2019 (quarter ended Mar 31, 2019), down 1.3% from $20,571 a year earlier.

Analysis

Grace Therapeutics (GRCE) Long-Term Investments (2018 - 2019) Analysis & Trends

At the end of FY2019 (ended Mar 31, 2019), Grace Therapeutics reported Long-Term Investments of $20,000, down 2.8% from FY2018.

  • Across earlier fiscal years, Long-Term Investments came in at $20,571 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 266.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 297.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 1.56 Bn
10 Grace Therapeutics 34.02 Mn -32.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 20,103.50
Mar 31, 2018 20,175.37
API Access

Grace Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=GRCE&period=max&api_key=YOUR_API_KEY